RICHMOND BRADLEY enters MARIZYME, INC. with 52.09K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 1/13/2022ACC: 0001493152-22-001143
Officer· Acting VP of Finance
Since Jul 2021
52.09K
Baseline shares
100% direct
52.09K
Direct ownership
1 position
148.37K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned52.09K
Total
52.09K direct52.09K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 52.09K | Direct |
| Total | 52.09K | 52.09K direct |
Derivative Holdings2
Warrants (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
112.01K
Shares owned
N/A
Exercise price
1.375
Expiration
—
Exercise window
—
Warrants (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
36.36K
Shares owned
N/A
Exercise price
1.375
Expiration
—
Exercise window
—
Total
Underlying
148.37K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrants (Right to Buy) Direct | Common Stock | 1.375 | — | — | 112.01K | N/A |
| Warrants (Right to Buy) Direct | Common Stock | 1.375 | — | — | 36.36K | N/A |
| Total | 148.37K | 0.00 | ||||